Dr. Thorsten Siess, Abiomed’s Chief Technology Officer and inventor of Impella® shares his insights on the history of Impella®
October 30, 2016
Subscribe or join the conversation by following us on Twitter: @ProtectedPCI
IMP-1332-16.V2
To learn more about the Impella® platform of heart pumps, including important risk and safety information associated with the use of the devices, please visit: www.protectedpci.com/indications-use-safety-information/
Subscribe to the Digital Community
Receive weekly updates including case review videos, tips and tricks, specialists opinions, and resources and downloads regarding Protected PCI and Cardiogenic Shock.
Related Content
- Register
TodayLive Training SeriesManagement of Patients in Cardiogenic ShockAppropriate Use of Impella for Support and TransportOctober 24th | Detroit Marriott - Specialist Opinions
Top Videos
Top Downloads
Scientific Presentations
Largest FDA Study of High-Risk PCI Patients Shows Improved Outcomes with Impella® Heart Pumps
Subscribe to the Digital Community
Receive weekly updates including case review videos, tips and tricks, specialists opinions, and resources and downloads regarding Protected PCI and Cardiogenic Shock.
